nafenopin has been researched along with pirinixic acid in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.04) | 18.7374 |
| 1990's | 15 (65.22) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, K; DePierre, JW; Eriksson, AM; Lundgren, B | 1 |
| Brodhecker, CA; Eacho, PI; Lanier, TL | 1 |
| Bergstrand, A; DePierre, JW; Karlsson, K; Lundgren, B | 1 |
| Fahl, WE; Goel, SK; Lalwani, ND; Reddy, JK | 1 |
| Butterworth, BE; Cattley, RC; Popp, JA; Richardson, KK; Smith-Oliver, T | 1 |
| Fahl, WE; Lalwani, ND; Reddy, JK; Reddy, MK | 1 |
| Gonzalez, FJ; McBride, OW; Sher, T; Yi, HF | 1 |
| Cunninghame, ME; Evans, JG; Lake, BG; Price, RJ | 1 |
| Greim, H; Leibold, E; Schwarz, LR | 1 |
| Alvares, K; Capone, JP; Dadras, SS; Fan, C; Iannaccone, PM; Rachubinski, RA; Rao, MS; Reddy, JK; Subramani, S; Yeldandi, AV | 1 |
| Davies, MJ; Lake, BG; Price, RJ; Rumsby, PC | 1 |
| Adam, M; Boie, Y; Kennedy, BP; Rushmore, TH | 1 |
| Beamand, JA; Cunninghame, ME; Lake, BG; Price, RJ | 1 |
| Bojes, HK; Thurman, RG | 2 |
| Anderson, NL; Eacho, P; Esquer-Blasco, R; Foxworthy, P; Richardson, F | 1 |
| James, NH; Roberts, RA | 1 |
| Roberts, RA | 1 |
| Armstrong, MJ; Ashby, J; Galloway, SM; Johnson, TE | 1 |
| Depierre, JW; Xie, Y; Yang, Q | 1 |
| Berger, W; Kainzbauer, E; Parzefall, W; Schulte-Hermann, R; Teufelhofer, O; Thurman, RG | 1 |
| Geoghagen, TE; Miller, KK; Prough, RA; Ripp, SL; Tamasi, V; Vila, E | 1 |
| Dizhe, EB; Lapikov, IA; Mogilenko, DA; Orlov, SV; Perevozchikov, AP; Shavva, VS | 1 |
1 review(s) available for nafenopin and pirinixic acid
| Article | Year |
|---|---|
Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators.
Topics: Animals; Anticholesteremic Agents; Apoptosis; Calcium; Cyproterone Acetate; DNA; DNA Fragmentation; Inositol Phosphates; Liver Neoplasms; Liver Neoplasms, Experimental; Nafenopin; Protein Kinase C; Pyrimidines; S Phase | 1996 |
22 other study(ies) available for nafenopin and pirinixic acid
| Article | Year |
|---|---|
Is the cytosolic catalase induced by peroxisome proliferators in mouse liver on its way to the peroxisomes?
Topics: Animals; Catalase; Clofibrate; Cytosol; Enzyme Induction; Liver; Male; Mice; Mice, Inbred C57BL; Microbodies; Nafenopin; Pyrimidines | 1992 |
Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Topics: Acetophenones; Animals; Bromodeoxyuridine; Clofibric Acid; DNA Replication; Immunohistochemistry; Liver; Liver Neoplasms, Experimental; Male; Microbodies; Nafenopin; Oxidation-Reduction; Pyrimidines; Rats; Rats, Inbred F344; Tetrazoles | 1991 |
Effects of dietary treatment with clofibrate, nafenopin or WY-14.643 on mitochondria and DNA in mouse liver.
Topics: Animals; Anticholesteremic Agents; Cell Nucleus; Clofibrate; DNA; Enzymes; Liver; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Mitochondria, Liver; Nafenopin; Propionates; Pyrimidines; Rats; Rats, Inbred Strains; Reference Values | 1990 |
Lack of covalent binding of peroxisome proliferators nafenopin and Wy-14 643 to DNA in vivo and in vitro.
Topics: Animals; Benzo(a)pyrene; DNA; Microbodies; Microsomes, Liver; Nafenopin; Propionates; Pyrimidines; Rats; Rats, Inbred F344; RNA | 1985 |
Effect of peroxisome proliferator carcinogens on unscheduled DNA synthesis in rat hepatocytes determined by autoradiography.
Topics: Animals; Autoradiography; Carcinogens; Cell Division; Diethylhexyl Phthalate; DNA Repair; In Vitro Techniques; Liver; Male; Microbodies; Nafenopin; Pyrimidines; Rats; Rats, Inbred F344 | 1986 |
Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk.
Topics: Animals; Animals, Newborn; Enzyme Induction; Female; Lactation; Liver; Microbodies; Milk; Nafenopin; Peptides; Pregnancy; Propionates; Pyrimidines; Rats; Rats, Inbred F344 | 1983 |
cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.
Topics: Acyl-CoA Oxidase; Amino Acid Sequence; Animals; Base Sequence; Chloramphenicol O-Acetyltransferase; Chromosome Mapping; Chromosomes, Human, Pair 22; Clofibrate; Cloning, Molecular; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Deoxyribonuclease HpaII; Deoxyribonucleases, Type II Site-Specific; DNA; Gene Library; Genetic Linkage; Humans; Lod Score; Mice; Microbodies; Mixed Function Oxygenases; Molecular Sequence Data; Nafenopin; Oligodeoxyribonucleotides; Oxidoreductases; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Promoter Regions, Genetic; Pyrimidines; Rabbits; Rats; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Thymidine Kinase; Transcription Factors | 1993 |
Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Topics: Animals; Carcinogens; Cell Division; Cricetinae; DNA Replication; Fatty Acids; Liver; Liver Neoplasms, Experimental; Male; Mesocricetus; Microbodies; Nafenopin; Organ Size; Oxidation-Reduction; Pyrimidines; Rats; Rats, Sprague-Dawley; Species Specificity | 1993 |
Inhibition of intercellular communication of rat hepatocytes by nafenopin: involvement of protein kinase C.
Topics: Animals; Cell Communication; Diethylhexyl Phthalate; Isoenzymes; Liver; Male; Nafenopin; Protein Kinase C; Pyrimidines; Rats; Rats, Wistar | 1994 |
An upstream region of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Animals; Clofibric Acid; Diethylhexyl Phthalate; Enoyl-CoA Hydratase; Fibric Acids; Genes, Reporter; Liver; Luciferases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Microbodies; Nafenopin; Pyrimidines | 1994 |
Effect of some peroxisome proliferators on transforming growth factor-beta 1 gene expression and insulin-like growth factor II/mannose-6-phosphate receptor gene expression in rat liver.
Topics: Animals; Clofenapate; Clofibric Acid; Corn Oil; Gene Expression; Liver; Male; Microbodies; Nafenopin; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 2; Transforming Growth Factor beta | 1994 |
Enantioselective activation of the peroxisome proliferator-activated receptor.
Topics: Acyl-CoA Oxidase; Animals; Base Sequence; Cells, Cultured; Clofibric Acid; DNA; Microbodies; Molecular Sequence Data; Nafenopin; Oxidoreductases; Propionates; Pyrimidines; Quinolines; Rats; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Regulatory Sequences, Nucleic Acid; Stereoisomerism; Transcription Factors; Transcriptional Activation | 1993 |
Culture of precision-cut liver slices: effect of some peroxisome proliferators.
Topics: Animals; Carnitine O-Acetyltransferase; Clofibric Acid; Culture Media; Culture Techniques; Fibric Acids; Liver; Male; Microbodies; Microscopy, Electron; Nafenopin; Oxidation-Reduction; Palmitoyl Coenzyme A; Pyrimidines; Rats; Rats, Sprague-Dawley; Time Factors | 1993 |
Peroxisome proliferators activate Kupffer cells in vivo.
Topics: Animals; Carcinogens; Cells, Cultured; Kupffer Cells; Male; Microbodies; Nafenopin; Phagocytosis; Pyrimidines; Rats; Rats, Inbred F344 | 1996 |
The effects of peroxisome proliferators on protein abundances in mouse liver.
Topics: Acetophenones; Amino Acid Sequence; Animals; Anticholesteremic Agents; Clofibric Acid; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Image Processing, Computer-Assisted; Liver; Male; Mice; Microbodies; Molecular Sequence Data; Nafenopin; Oxidation-Reduction; Proteins; Pyrimidines; Rats; Tetrazoles | 1996 |
Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
Topics: Animals; Apoptosis; Blood; Clofenapate; Cricetinae; Culture Media; DNA Damage; DNA Replication; Dogs; Guinea Pigs; Homeostasis; Male; Mice; Microbodies; Nafenopin; Phenobarbital; Pyrimidines; Rats; Species Specificity; Transforming Growth Factors | 1996 |
Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
Topics: Animals; Antihypertensive Agents; Antioxidants; Caprylates; Cell Division; Hypolipidemic Agents; In Vitro Techniques; Lipid Peroxidation; Male; Microbodies; Microsomes, Liver; Nafenopin; Oxidative Phosphorylation; Perfusion; Pyrimidines; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 1996 |
The genetic toxicity of the peroxisome proliferator class of rodent hepatocarcinogen.
Topics: Animals; CHO Cells; Clofenapate; Cricetinae; Diethylhexyl Phthalate; Humans; Molecular Structure; Nafenopin; Peroxisome Proliferators; Pyrimidines | 2000 |
Effects of peroxisome proliferators on the thymus and spleen of mice.
Topics: Animals; Aspirin; Atrophy; B-Lymphocytes; Caprylates; Cell Cycle; Cell Division; Diethylhexyl Phthalate; DNA; Fluorocarbons; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nafenopin; Peroxisome Proliferators; Pyrimidines; Spleen; T-Lymphocytes; Thymus Gland | 2000 |
Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes.
Topics: Animals; DNA Replication; Hepatocytes; Kupffer Cells; Nafenopin; Peroxisome Proliferators; Pyrimidines; Rats | 2001 |
Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cells, Cultured; Data Interpretation, Statistical; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Genes, Reporter; Hepatocytes; Luciferases; Male; Mutation; Nafenopin; Peroxisome Proliferators; Phosphorylation; Plasmids; PPAR alpha; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transfection | 2008 |
Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells.
Topics: Apolipoprotein A-I; Cell Line, Tumor; Down-Regulation; Hepatocyte Nuclear Factor 4; Humans; Ligands; Liver X Receptors; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Nafenopin; NF-kappa B; Orphan Nuclear Receptors; PPAR alpha; Pyrimidines; Tumor Necrosis Factor-alpha | 2009 |